Bristol-Myers Squibb Company (NYSE:BMY) is one of the best pharma stocks to invest in. On December 4, Jefferies reiterated a Buy rating on Bristol-Myers Squibb Company (NYSE:BMY) with a price target of $68. Leerink Maintains Outperform Rating as Bristol Myers (BMY) Expands ADEPT-2 Enrollment The same day, Scotiabank lifted the price target on Bristol-Myers Squibb Company (NYSE:BMY) to$53 from $45 while maintaining a Sector Perform rating on the shares. The firm told investors that it anticipates several ...